| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00021 | 1 |